Activity

Activity ID

14931

Expires

March 24, 2029

Format Type

Journal-based

CME Credit

1

Fee

$30

CME Provider: JAMA Network Open

Description of CME Course

Importance  Patients with cancer living in persistent poverty (PP) are at risk for worse oncologic outcomes. Existing welfare interventions typically focus on current poverty and may not benefit patients in PP if the underlying mechanisms are unique; thus, modifiable targets are needed to inform future policy efforts.

Objectives  To compare clinical outcomes for patients diagnosed with colon cancer based on the share of census tracts per zip code that were in PP at the time of diagnosis and to explore 2 potential mechanisms connecting PP and disease-specific mortality.

Design, Setting, and Participants  This retrospective cohort study using data from a statewide cancer registry included all patients diagnosed with colon cancer in California from 2017 to 2020. Patients with multiple malignant tumors and patients diagnosed based on only their death certificate were excluded. Data were analyzed from February 2024 to February 2025.

Exposure  Proportion of census tracts per zip code designated as being in PP at the time of diagnosis (0, 0.01-0.25, 0.26-0.50, and >0.50).

Main Outcomes and Measures  The primary outcome was disease-specific mortality. Secondary outcomes included overall mortality, stage at diagnosis, and receipt of guideline-concordant care. Fine-Gray competing risk survival models were used to calculate risk-adjusted mortality and to evaluate the relative contribution of access to care and quality of care as potential mediators of the association between PP and disease-specific mortality. Charlson comorbidity indices ranged from 0 to 14, with higher values indicating higher comorbidity.

Results  In total, 20 015 patients (mean [SD] age at diagnosis, 65.9 [14.0] years; 51.3% male) met inclusion criteria, and the majority (66.3%) resided in zip codes with no PP. Patients living in areas with higher PP ratios were younger (eg, mean [SD] age at diagnosis, 64.3 [14.1] years for >50% PP vs 66.3 [14.1] years for no PP), more likely to identify as Hispanic (eg, 45.5% for >50% PP vs 19.2% for no PP) or non-Hispanic Black (eg, 15.7% for >50% PP vs 4.9% for no PP), and had higher Charlson comorbidity indices (eg, mean [SD] score, 1.3 [1.8] for >50% PP vs 1.2 [1.7] for no PP). After adjustment for demographic and clinical variables, higher shares of PP were associated with higher rates of disease-specific mortality: hazard ratios, 1.20 (95% CI, 1.07-1.36) and 1.19 (95% CI, 1.01-1.42) for PP ratios 0.26-0.50 and higher than 0.50, respectively. Health care practitioner density did not appear to mediate this association. However, adjusting for the receipt of guideline-concordant care affected both the magnitude and the statistical significance of the model, suggesting potential mediation.

Conclusions and Relevance  In this cohort study, living in PP was associated with disease-specific mortality among patients diagnosed with colon cancer. The Persistent Poverty Initiative presents a unique opportunity to improve our understanding of PP and to support efforts to extend treatment to all US residents with cancer.

Disclaimers

1. This activity is accredited by the American Medical Association.
2. This activity is free to AMA members.

Register for this Activity

ABMS Member Board Approvals by Type
More Information
Commercial Support?
No

NOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.

Educational Objectives

To identify the key insights or developments described in this article.

Keywords

Health Policy, Guidelines, Health Disparities, Health Inequities, Colorectal Cancer

Competencies

Medical Knowledge

CME Credit Type

AMA PRA Category 1 Credit

DOI

10.1001/jamanetworkopen.2025.51212

View All Activities by this CME Provider

The information provided on this page is subject to change. Please refer to the CME Provider’s website to confirm the most current information.